DVT Preventive Pump Market Size | Report Analysis 2022, 2028

The DVT preventive pump market was valued at US$ 383.86 million in 2021; it is estimated to grow at a CAGR of 4.4% from 2022 to 2028.

DVT pumps are pneumatic compression pumps that are used to prevent people from getting deep vein thrombosis (DVT), which can be life-threatening. DVT pumps deliver pressure to the upper or lower extremities to increase blood flow in these areas to prevent blood clots. People especially susceptible to thrombosis have recently undergone surgery and are immobile or sedentary. Prolonged inactive states cause blood to pool around veins slowing circulation, thus leading to blot clotting. 

Market Insights

Significant Surge in Geriatric Population and Rising Prevalence of Deep Vein Thrombosis

DVT is a condition that occurs when a blood clot (thrombus) is formed in one or more veins, especially in the lower extremities. It can cause pain and swelling, and in some cases, it leads to pulmonary embolism, a life-threatening condition. Cardiovascular and stroke patients are more prone to DVT as the condition affects the overall blood flow of the body. According to the Centers for Disease Control and Prevention (CDC), approximately 900,000 people are expected to be affected by DVT annually in the US, and ~60,000-100,000 deaths are registered in the country every year. Moreover, the geriatric population is susceptible to DVT as they have restricted movements along with other chronic conditions, such as diabetes and orthopedic disorders, which contribute to the prevalence of DVT. According to the National Library of Medicine, the risk of venous thromboembolism (VTE) is higher in the population aged 65 years and above. Additionally, coexisting comorbidities exhibit a high mortality rate among the geriatric population. Thus, the rising prevalence of DVT across the globe is driving the growth of the DVT preventive pump market

Strategic Insights

Several economies such as the US, the UK, Canada, Japan, China, India, and South Korea are witnessing considerable modernization of healthcare facilities and improvements in healthcare services. As a result, the life expectancy of people has increased in these countries, leading to a growth in their geriatric population base. According to the data by the WHO in October 2022, the global geriatric population is estimated to rise from 12% in 2015 to 22% by 2050. Further, the US Census Bureau report states that the number of people aged 65 and above is anticipated to grow from 46 million in 2016 to over ~98 million by 2060 in the US, registering an increase from ~15% to ~24% during this period. Similarly, according to a report published by the United Nations World Population Ageing, Europe had the world's highest percentage (i.e., 25%) of people aged more than 60 years in 2017. Further, all regions of the world, except Africa, are anticipated to account for over ~25% of the population to be aged 60 and above by 2050. As per the same report, underdeveloped and developing countries are expected to account for ~80% of this population growth.

Thus, the rising prevalence of DVT and the surge in the geriatric population has increased the incidence of DVT across the world, which is driving the growth of the DVT preventive pumps market.   

Type Insights

Based on type, the DVT preventive pump market is bifurcated into lower extremity and upper extremity. The lower extremity segment held a larger market share of US$ 279.12 million in 2021; further, it is anticipated to register the highest CAGR of 4.8% during the forecast period.

DVT Preventive Pump Market, by Type – 2021 and 2028

Get more information on this report : Request Free Sample PDF

Based on the end user, the DVT preventive pump market is segmented into hospitals and clinics, surgical centers, and others. The hospitals and clinics segment accounted for the largest share of the market in 2021, and it is expected to register the highest CAGR of 5.0% during the forecast period.

Inorganic strategies such as mergers and acquisitions are highly adopted by companies in the DVT preventive pump market. The recent key market developments are listed below:

• In Feb 2019, Colfax Corporation acquired DJO Global, Inc. from an investor group led by private equity funds managed by Blackstone for US$ 3.15 billion. This acquisition is the next step in the strategic evolution of Colfax, which creates a new growth platform in the high-margin orthopedic solutions market.

Company Profiles

• Devon Medical Products Inc.          
• Breg Inc      
• Bio Compression Systems Inc       
• Cardinal Health Inc            
• Arjo AB        
• Mego Afek Ltd        
• DJO LLC       
• Currie Medical Specialities Inc       
• Zimmer Biomet Holdings Inc         
• Medcaptain Medical Technology Co Ltd      
• ThermoTek Inc